“…Presently nuclear medicine techniques involving single photon emission computed tomography (SPECT) and positron emission tomography (PET) along with the more familiar imaging techniques such as, conventional radiography (X rays), computed tomography (CT) scans, magnetic resonance (MR) imaging, and ultrasound play a critical role in tumor diagnosis (Dodd, ; Rudin & Weissleder, ). The principal advantage of nuclear imaging techniques lies in its ability to not only identify the location of cancerous and diseased tissue, but also to provide simultaneous information regarding its physiological state, which is important to devising strategies to effectively combat the disease (Holland, Ferdani, Anderson, & Lewis, ; Warwick & Lotz, ). Diagnostic radiopharmaceuticals, having the capability of noninvasively detecting tumors at an early stage of the disease play a critical role in the rapid and early diagnosis of tumors making development of radiolabeled agents with improved characteristics for tumor diagnosis an active area of research in the radiopharmaceutical sciences.…”